Global Plasmid DNA Manufacturing Services Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Plasmid DNA Manufacturing Services Market Insights, Forecast to 2034
Plasmid DNA manufacturing services refer to specialized processes offered by biotechnology companies to produce plasmid DNA at various scales and quantities. Plasmid DNA is a small, circular piece of DNA commonly used in biotechnology and genetic engineering applications, such as gene therapy, genetic research, vaccine development, and recombinant protein production.
Market Analysis and InsightsGlobal Plasmid DNA Manufacturing Services Market
Global Plasmid DNA Manufacturing Services market is expected to reach to US$ 1508.1 million in 2023, with a positive growth of %, compared with US$ 1297.3 million in 2022. Backed with the increasing demand from downstream industries, Plasmid DNA Manufacturing Services industry is evaluated to reach US$ 3106.6 million in 2033. The CAGR will be 12.8% during 2023 to 2033.
The development and commercialization of gene editing technologies like CRISPR-Cas have increased the demand for high-quality plasmid DNA as essential tools for gene editing research and applications.
Report Covers
This report presents an overview of global Plasmid DNA Manufacturing Services market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Plasmid DNA Manufacturing Services market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Vigene Biosciences
Aldevron
Creative Biogene
Thermo Fisher Scientific Inc.
Kaneka Eurogentec SA
AGC Biologics
Andelyn Biosciences
Biomay
VGXI, Inc.
VectorBuilder
Xpress Biologics
Biovian
WuXi Advanced Therapies
Catalent, Inc
Charles River Laboratories
Esco Aster Pte. Ltd
Waisman
Boehringer Ingelheim Biopharmaceuticals GmbH
Segment by Type
Research-Grade Plasmids
High Quality (HQ) / GMP-Ready™ Plasmids
CGMP Plasmid
Others
Medical Industry
Biological Industry
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Plasmid DNA Manufacturing Services introduction, etc. Plasmid DNA Manufacturing Services Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Plasmid DNA Manufacturing Services
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Plasmid DNA Manufacturing Services Market
Global Plasmid DNA Manufacturing Services market is expected to reach to US$ 1508.1 million in 2023, with a positive growth of %, compared with US$ 1297.3 million in 2022. Backed with the increasing demand from downstream industries, Plasmid DNA Manufacturing Services industry is evaluated to reach US$ 3106.6 million in 2033. The CAGR will be 12.8% during 2023 to 2033.
The development and commercialization of gene editing technologies like CRISPR-Cas have increased the demand for high-quality plasmid DNA as essential tools for gene editing research and applications.
Report Covers
This report presents an overview of global Plasmid DNA Manufacturing Services market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Plasmid DNA Manufacturing Services market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Vigene Biosciences
Aldevron
Creative Biogene
Thermo Fisher Scientific Inc.
Kaneka Eurogentec SA
AGC Biologics
Andelyn Biosciences
Biomay
VGXI, Inc.
VectorBuilder
Xpress Biologics
Biovian
WuXi Advanced Therapies
Catalent, Inc
Charles River Laboratories
Esco Aster Pte. Ltd
Waisman
Boehringer Ingelheim Biopharmaceuticals GmbH
Segment by Type
Research-Grade Plasmids
High Quality (HQ) / GMP-Ready™ Plasmids
CGMP Plasmid
Others
Segment by Application
Medical Industry
Biological Industry
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Plasmid DNA Manufacturing Services introduction, etc. Plasmid DNA Manufacturing Services Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Plasmid DNA Manufacturing Services
Chapter 13Methodology and Data Sources adopted by MRAResearch